Unicon Pharma, a US-based provider of compliance, validation, and workforce solutions for the life sciences industry, has announced a strategic partnership with Bengaluru-based VRR Life Sciences to expand global computer system validation (CSV) services and support digital transformation initiatives in the sector.

Operating under the unified brand VRR Life Sciences, a Unicon Company, this collaboration marks a significant milestone in Unicon's strategy to deliver scalable, tech-enabled compliance solutions to pharmaceutical, biotech, and medical device clients across the United States.

This partnership follows Unicon's 2024 collaboration with Core to enhance CQV services and aligns with its broader vision of building an integrated global platform for validation and regulatory excellence. By combining Unicon's strong US market presence with VRR's extensive CSV expertise and offshore delivery model, the partnership aims to provide enhanced value through speed, cost-efficiency, and quality assurance.

Ravi Kollipara, CEO, Unicon Pharma, said, “Our clients are operating in a time of regulatory transformation, with increasing expectations around data integrity, digital systems, and global compliance. With VRR Life Sciences joining our platform, we are not only expanding our technical depth, we are reinforcing our ability to deliver high-quality results at scale.”

With a proven track record of successful CSV and regulatory projects for multinational clients, VRR Life Sciences brings AI-driven tools, automation frameworks, and a scalable team of validation experts to the partnership. This collaboration also provides VRR with a strategic commercial entry into the US market.

Gireesh T., CEO of VRR Life Sciences, said, “Joining with Unicon allows us to bring our proven methods to new markets while aligning with a partner who shares our values and standards. It's an important step forward for our team and the clients we'll serve together.”

VRR Life Sciences will focus on enterprise-level CSV projects, data integrity remediation, and IT compliance initiatives, helping life sciences organisations reduce risk, enhance quality, and accelerate delivery across the development lifecycle.